When: January 26, 10:30 – 13:00
What: IHI is the successor of the Innovative Medicines Initiative (IMI) and aims to translate health research and innovation into tangible benefits for patients and society.
The event will introduce the new partnership and describe what´s new compared to IMI and what will stay the same. Further, IHI staff will present opportunities for stakeholders to get involved in IHI, for example by applying to become a member of the IHI Science and Innovation Panel (SIP), or by becoming an expert evaluator. They will also offer a preview of the draft topics under consideration for inclusion in the first IHI call for proposals.
Who: Researchers, who are interested in engaging in public-private partnerships with industry partners and other relevant stakeholders for a more integrated approach to healthcare, covering prevention, diagnosis, treatment and disease management.
How: You need to register for the event here
Presenter: IHI Executive Director dr Pierre Meulien et al.